Showing results (2571-2580 of 2,705) with videos related to
Sort By:
Pageof 271
ACS Chemical Neuroscience|April 28, 2018
A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJerri M Rook, Jeanette L Bertron, Hyekyung P Cho, et al.Head & Neck|July 11, 2017
Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgeryMartina A Broglie, Sandro J Stoeckli, Rafael Sauter, et al.Iscience|December 8, 2021
STING regulates peripheral nerve regeneration and colony stimulating factor 1 receptor (CSF1R) processing in microgliaGiulio Morozzi, Julian Rothen, Gauthier Toussaint, et al.ESMO Open|July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14D König, S Savic Prince, S Hayoz, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.Journal of Medicinal Chemistry|September 21, 2013
Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)Mark Turlington, Meredith J Noetzel, Aspen Chun, et al.Medicine and Science in Sports and Exercise|May 14, 2024
Factors Associated with Fatigue in COVID-19 ICU SurvivorsDjahid Kennouche, Clément Foschia, Callum G Brownstein, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2015
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse ModelA Ghoshal, J M Rook, J W Dickerson, et al.Blood Neoplasia|August 14, 2025
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Iman Chanchiri, Ahmed Ludvigsen Al-Mashhadi, et al.Journal of Medicinal Chemistry|August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.Pageof 271